Concepedia
Statistics
Publications
69
Citations
3.1K
H-Index
30
Active since
2004
Affiliations
Lundbeck (Denmark)(Current)
University of Copenhagen
Lundbeck (United States)
AstraZeneca (Sweden)
Eli Lilly (United Kingdom)
Christoffer Bundgaard is an author at Lundbeck (Denmark) specializing in pharmacology, neuropharmacology, and medicine.
Publications per year
2004–2024
Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 362 citations
Medicine, Pharmacology, Psychiatry +15
Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
Arne Mørk, Alan L. Pehrson, Lise T. Brennum et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 268 citations
Medicine, Medicinal Chemistry, Pharmacology +17
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs<i>in Vitro</i>and<i>in Vivo</i>
Karen Thompson, Elham Khajehali, Sophie J. Bradley et al. · ACS Pharmacology & Translational Science · 2018 · 195 citations · Full text
Medicine, Neuroscience, Pharmacology +13
Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development
Irena Loryan, Andreas Reichel, Bo Feng et al. · Pharmaceutical Research · 2022 · 151 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +14
Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
Kenji Maeda, Linda Lerdrup, Haruhiko Sugino et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 130 citations
1–5 of 69